HEPATECELLULAR CARCINOMA
Clinical trials for HEPATECELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HEPATECELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for HEPATECELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Triple-Threat attack on tough liver cancer
Disease control Recruiting nowThis study is testing a three-part treatment for advanced liver cancer that has spread into a major vein in the liver. The treatment combines immunotherapy (QL1706), a drug that blocks tumor blood supply (bevacizumab), and chemotherapy delivered directly into the liver's artery. …
Matched conditions: HEPATECELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Apr 13, 2026 20:18 UTC
-
AI model aims to spot High-Risk liver cancer patients early
Knowledge-focused Recruiting nowThis study tests a computer model that uses patient data and scans to predict if early-stage liver cancer will come back within 2 years after surgery. About 353 adults with liver cancer will join, and their health will be tracked for 2 years. The goal is to see if the AI can accu…
Matched conditions: HEPATECELLULAR CARCINOMA
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 07:52 UTC